In the fight against cancer, genes are key. Genetic tests, along with a patient’s lifestyle markers (diet, exercise, smoking), can clearly signal when pre-emptive strategies should be implemented. But unless genetic services, with their time-intensive data-gathering and expensive workforce, can be made more practical, physicians often skip the process altogether.
CancerIQ's "cancer risk clinic in a box" makes it faster and cheaper for physicians to identify high-risk patients and navigate them towards services that can pre-empt or prevent cancer. By automating the most time-consuming admin tasks that keep community-based physicians from offering genetic services, we improve patient access to life-saving medical care.
Our product suite contains predictive analytics and screening tools to identify at-risk patients; clinical guidance with proven outcomes; a digital genetic test ordering platform and patient management and education tools.
CancerIQ's "cancer risk clinic in a box" makes it faster and cheaper for physicians to identify high-risk patients and navigate them towards services that can pre-empt or prevent cancer. By automating the most time-consuming admin tasks that keep community-based physicians from offering genetic services, we improve patient access to life-saving medical care.
Our product suite contains predictive analytics and screening tools to identify at-risk patients; clinical guidance with proven outcomes; a digital genetic test ordering platform and patient management and education tools.
Location: United States, California, San Francisco
Employees: 11-50
Phone: +1 312-761-3360
Total raised: $19M
Founded date: 2013
Investors 6
| Date | Name | Website |
| - | 1776 Ventu... | 1776.ventu... |
| 21.03.2022 | OSF Health... | osfhealthc... |
| - | HealthX Ve... | healthxven... |
| 11.03.2022 | McKesson V... | ventures.m... |
| - | Impact Eng... | theimpacte... |
| - | Rock Healt... | rockhealth... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.03.2022 | Series B | $14M | - |
| 14.08.2020 | Series A | $5M | HealthX Ve... |
Mentions in press and media 31
| Date | Title | Description |
| 26.08.2024 | CancerIQ Receives Revenue Based Financing From Decathlon Capital Partners | CancerIQ, a Chicago, IL-based precision health platform that empowers healthcare providers to personalize cancer prevention and early detection for their patients, received a revenue based financing from Decathlon Capital Partners. The amou... |
| 22.08.2024 | Revolutionizing Cancer Care: The Rise of Personalized Detection and Prevention | In the world of healthcare, cancer remains a formidable adversary. But new strategies are emerging, transforming the landscape of cancer detection and prevention. Two significant players, CancerIQ and Hackensack Meridian Health (HMH), are l... |
| 21.08.2024 | CancerIQ Raises Growth Capital for Personalized Cancer Detection | What You Should Know: – CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon... |
| 20.08.2024 | Hackensack Meridian Health Launches Cancer Risk Assessment Program | What You Should Know: – Hackensack Meridian Health (HMH) launches comprehensive cancer risk and early detection program designed to identify individuals at higher risk for cancer and enable earlier diagnosis. – Powered by CancerIQ’s precisi... |
| 28.05.2024 | CancerIQ Co-founder Receives Medal of Honor for Achievements in Breast Cancer Prevention and Early Detection | Dr. Olufunmilayo Olopade, MD with her daughter and CancerIQ Co-Founder, Feyi Ayodele, MBA Dr. Olopade acceptance of Ellis Island Medal of Honor coincides with publication of her team's landmark study on breast cancer risk in women of Africa... |
| 18.04.2023 | CancerIQ Adds Dr. Carladenise Edwards to Board of Directors | “I am adamant about being involved and engaged with companies that want to change how care is accessed, financed, and delivered,” said Dr. Edwards. CHICAGO (PRWEB) April 18, 2023 CancerIQ, the platform powering early cancer detection and pr... |
| 24.03.2023 | CancerIQ Unveils New Service Offerings and Integrated Risk Score Calculator at NCoBC 2023 | We want to ensure health systems can bridge genetic counseling and patient navigation resource gaps, so they can more equitably offer access to services patients need to stay ahead of cancer. - Feyi Olopade Ayodele, CEO Chicago, IL (PRWEB) ... |
| 04.03.2022 | CancerIQ Raises $14M in Series B Funding | Feyi Olopade Ayodele and Olufunmilayo Olopade, MD. (Photo: Business Wire) CancerIQ, a Chicago, IL-based cancer detection and prevention company, raised $14M in Series B funding. The round was led by Merck Global Health Innovation Fund and A... |
| 03.03.2022 | Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention | CancerIQ Co-Founders Feyi Olopade Ayodele & Olufunmilayo (Funmi) Olopade, MD What You Should Know: – CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it ... |
| 03.03.2022 | Drug discovery startup ArrePath scores $20M and more digital health fundings | Photo: filadendron/Getty Images |
Show more